Probiotic effects on experimental graft-versus-host disease: let them eat yogurt
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Acute graft-versus-host disease (aGVHD) often limits feasibility and outcome of allogeneic bone marrow transplantation. Current pathophysiologic concepts of aGVHD involve conditioning regimens, donor-derived T cells, proinflammatory cytokines, and bacterial lipopolysaccharide (LPS) as a major trigger for aGVHD. LPS derives mostly from gram-negative bacteria and can enter circulation through the impaired mucosal barrier after the conditioning regimen. Probiotic microorganisms have been shown to alter the composition of the intestinal microflora and thereby mediate anti-inflammatory effects. We hypothesized that modifying the enteric flora using the probiotic microorganism Lactobacillus rhamnosus GG, would ameliorate aGVHD. Here we show that oral administration of Lactobacillus rhamnosus GG before and after transplantation results in improved survival and reduced aGVHD. Furthermore, subculturing of mesenteric lymph node tissue revealed a reduced translocation of enteric bacteria. Our findings suggest that alteration of the intestinal microflora plays an important role in the initiation of experimental aGVHD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The administration of the probiotic Lactobacillus rhamnosus GG alone or in combination with Ciprofloxacin before and during transplantation in mice was associated with reduced rates of GVHD and improved overall survival”
From The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy (2018) · cites this paper as Gerbitz et al., 2004
Citations
Cites
Inflammatory bowel disease: Etiology and pathogenesis
Fiocchi, C. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70381-6 · Cited by 2,059
Cooke, K., Kobzik, L., Martin, T., Brewer, J., Delmonte, J. J., Crawford, J., & Ferrara, J. (1996) · Blood · doi:10.1182/blood.v88.8.3230.bloodjournal8883230 · Cited by 963
Rath, H. C., Herfarth, H. H., Ikeda, J. S., Grenther, W. B., Hamm, T. E., Balish, E., Taurog, J. D., Hammer, R. E., Wilson, K. H., & Sartor, R. B. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118878 · Cited by 834
Hill, G. R., Crawford, J. M., Cooke, K. R., Brinson, Y. S., Pan, L., & Ferrara, J. L. M. (1997) · Blood · doi:10.1182/blood.v90.8.3204 · Cited by 832
Tannock, G. W., Munro, K., Harmsen, H. J. M., Welling, G. W., Smart, J., & Gopal, P. K. (2000) · Applied and Environmental Microbiology · doi:10.1128/aem.66.6.2578-2588.2000 · Cited by 679
Cooke, K. R., Hill, G. R., Crawford, J. M., Bungard, D., Brinson, Y. S., Delmonte, J., & Ferrara, J. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4285 · Cited by 335
Bekkum, D. W. V., Roodenburg, J., Heidt, P. J., & Waaij, D. V. D. (1974) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/52.2.401 · Cited by 330
Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction
Murai, M., Yoneyama, H., Ezaki, T., Suematsu, M., Terashima, Y., Harada, A., Hamada, H., Asakura, H., Ishikawa, H., & Matsushima, K. (2003) · Nature Immunology · doi:10.1038/ni879 · Cited by 290
Beelen, D. W., Elmaagacli, A., Müller, K.-D., Hirche, H., & Schaefer, U. W. (1999) · Blood · doi:10.1182/blood.v93.10.3267.410k22_3267_3275 · Cited by 270
Hill, G. R., Cooke, K. R., Teshima, T., Crawford, J. M., Keith, J. C., Brinson, Y. S., Bungard, D., & Ferrara, J. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3132 · Cited by 268
Cited by
The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy
Gopalakrishnan, V., Helmink, B. A., Spencer, C. N., Reuben, A., & Wargo, J. A. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.015 · Cited by 1,392
“The administration of the probiotic Lactobacillus rhamnosus GG alone or in combination with Ciprofloxacin before and during transplantation in mice was associated with reduced rates of GVHD and improved overall survival (Gerbitz et al., 2004).”
BackgroundInfluentialAdvances in graft-versus-host disease biology and therapy
Blazar, B. R., Murphy, W. J., & Abedi, M. (2012) · Nature Reviews Immunology · doi:10.1038/nri3212 · Cited by 880
Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease
Jenq, R. R., Taur, Y., Devlin, S. M., Ponce, D. M., Goldberg, J. D., Ahr, K. F., Littmann, E. R., Ling, L., Gobourne, A. C., Miller, L. C., et al. (2015) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2015.04.016 · Cited by 748
“Because increased Enterococcus may be associated with GVHD [40], we evaluated if Enterococcus, or potentially beneficial bacterial genera (Lactobacillus [41, 42] and Bacteroides [43]) were associated with GVHD-related mortality in our patient population.”
BackgroundRegulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation
Jenq, R. R., Ubeda, C., Taur, Y., Menezes, C. C., Khanin, R., Dudakov, J. A., Liu, C., West, M. L., Singer, N. V., Equinda, M. J., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112408 · Cited by 626
“Other approaches include targeting anaerobic bacteria (Beelen et al., 1999) and introducing potentially beneficial bacteria (Gerbitz et al., 2004), with some reduction of GVHD.”
BackgroundHoller, E., Butzhammer, P., Schmid, K., Hundsrucker, C., Koestler, J., Peter, K., Zhu, W., Sporrer, D., Hehlgans, T., Kreutz, M., et al. (2014) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2014.01.030 · Cited by 544
“Further evidence for a role of the intestinal microbiome in GVHDwas suggested by protection from experimental GVHD by the prophylactic application of probiotic lactobacilli in mice [6] and by clinical data suggesting that prophylactic use of ciprofloxacin/metronidazole antibiotics may reduce GVHD [7].”
Self-citation
Metadata
- Authors
- Gerbitz, A., Schultz, M., Wilke, A., Linde, H.-J., Schölmerich, J., Andreesen, R., & Holler, E.
- Affiliations
- Institute of Medical Microbiology and Hygiene (DE)
- From the Department of Hematology/Oncology, the Department of Internal Medicine, and the Institute of Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany; and the Department of Hematology/Oncology, University of Munich, Munich, Germany.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2004-06-01
- Volume
- 103
- Issue
- 11
- Pages
- 4365-4367
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2005584838
- Cited by
- 186
- References
- 18
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 4 · 2023: 11 · 2022: 7 · 2021: 10 · 2020: 12 · 2019: 11 · 2018: 10 · 2017: 16 · 2016: 15 · 2015: 13 · 2014: 8 · 2013: 6 · 2012: 9
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- University of Regensburg Publication Server (University of Regensburg) (submittedVersion)
- Funders
- Valio
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- acute graft-versus-host disease, probiotics, Lactobacillus rhamnosus GG, gut microbiota, allogeneic bone marrow transplantation, lipopolysaccharide, bacterial translocation, mesenteric lymph nodes, oral administration, anti-inflammatory activity
- MeSH terms
- Animals, Graft vs Host Disease, Lactobacillus, Mice, Inbred C57BL, Yogurt, Bone Marrow Transplantation, Bacterial Translocation, Probiotics, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Probiotic effects on experimental graft-versus-host disease: let them eat yogurt. https://app.cochat.ai/papers/10.1182/blood-2003-11-3769
- The paper
- Gerbitz, A., Schultz, M., Wilke, A., Linde, H.-J., Schölmerich, J., Andreesen, R., & Holler, E. (2004). Probiotic effects on experimental graft-versus-host disease: let them eat yogurt. Blood. https://doi.org/10.1182/blood-2003-11-3769
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.